Overview

Sirolimus for Retinal Astrocytic Hamartoma

Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
A single patient study using intravitreal Sirolimus to treat a patient with multiple retinal astrocytic hamartomas (RAH) of both eyes.
Phase:
N/A
Details
Lead Sponsor:
The Hospital for Sick Children
Treatments:
Sirolimus